Trump administration teams up with Big Pharma to block drug pricing transparency

[brummelben]

This article originally appeared on the International Business Times.

A week before his inauguration, Donald Trump said that when it came to drug prices, pharmaceutical companies were “getting away with murder”—and he pledged to take decisive action to reduce the rising cost of medicine. Six weeks into his presidency, though, his government has moved to help drug companies block shareholder initiatives designed to help bring more scrutiny to drug price increases.

With drug prices skyrocketing in the United States, investor groups last year filed shareholder resolutions with 13 drug companies that—if passed—would force their boards to more meticulously detail their price increases for major medicines, and to provide “the rationale and criteria used for these price increases.” Days after Trump met with pharmaceutical industry CEOs at the White House, the Securities and Exchange Commission endorsed drug companies’ moves to block the resolutions from being voted on by shareholders at their annual meetings. The SEC move followed Trump promoting Republican SEC commissioner Michael Piwowar to serve as acting chairman of the agency.

TRUMP LIES ONCE AGAIN TO THE AMERICAN PEOPLE

 

[MarathonMike]

So that's the only way you think we can have transparency on drug costs? Shareholder resolutions filed by "Investor Groups"?

 

[brummelben]

So that's the only way you think we can have transparency on drug costs? Shareholder resolutions filed by "Investor Groups"?

Its a start, what other options do we have? The point is that Trump lied to you again

 

[Norman]

This article originally appeared on the International Business Times.

A week before his inauguration, Donald Trump said that when it came to drug prices, pharmaceutical companies were “getting away with murder”—and he pledged to take decisive action to reduce the rising cost of medicine. Six weeks into his presidency, though, his government has moved to help drug companies block shareholder initiatives designed to help bring more scrutiny to drug price increases.

With drug prices skyrocketing in the United States, investor groups last year filed shareholder resolutions with 13 drug companies that—if passed—would force their boards to more meticulously detail their price increases for major medicines, and to provide “the rationale and criteria used for these price increases.” Days after Trump met with pharmaceutical industry CEOs at the White House, the Securities and Exchange Commission endorsed drug companies’ moves to block the resolutions from being voted on by shareholders at their annual meetings. The SEC move followed Trump promoting Republican SEC commissioner Michael Piwowar to serve as acting chairman of the agency.

TRUMP LIES ONCE AGAIN TO THE AMERICAN PEOPLE

Did you actually have an argument?

Of course not, just random rambling and disconnected gibberish. As to be expected. The result of years of indoctrination to the anti-Trump hard-left faith.